Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feederfiercepharma.com
FiercePharma
Get the latest updates from FiercePharma directly as they happen.
Follow now 362 followers
Latest posts
Last updated 1 day ago
Sanofi, Regeneron score their 7th indication for Dupixent with FDA nod to treat hives condition
1 day ago
Sanofi and Regeneron have scored an FDA approval for Dupixent in its...
FDA moves to block biopharma employees from serving on advisory committees
1 day ago
Employees of companies regulated by the FDA—such as pharmas or biotechs—are no...
RFK Jr.'s FDA staff cuts claimed key user fee negotiators, threatening renewal talks with pharma: Reuters
1 day ago
Staff cuts at the FDA have reached key negotiators in charge of...
Talent, Training and Scientific Infrastructure. All in NC.
1 day ago
North Carolina has the talent, training resources, scientific infrastructure, and lower operating...
Navigating Trump’s tariffs for pharma
1 day ago
This week on “The Top Line,” we unpack the latest tariffs from...
Fierce Pharma Asia—The latest on Trump's tariffs; Leqembi's EU approval; Kyowa Kirin's biologics plant
1 day ago
The Trump administration is expected to announce tariffs on pharmaceuticals "in the...
Ligand's Pelthos unit joins forces with Channel Therapeutics in merger centered on launch of molluscum gel Zelsuvmi
2 days ago
The combined company is supported by $50 million in capital from Ligand...
Eli Lilly is overtaking Novo Nordisk in the diabetes, obesity market: BMO analysts
2 days ago
The tortoise (Eli Lilly) has caught the hare (Novo Nordisk), according to...
GSK kicks off Blenrep's market return with first myeloma combo nod in UK
2 days ago
GSK has secured the first regulatory approval for Blenrep since the antibody-drug...
Life Science Data Needs an Upgrade: Veeva Has Answers
2 days ago
Veeva’s Anthony Billinger breaks down how outdated commercial data models are costing...
Recently departed CBER director warns FDA staff cuts could upend drug review timelines as early as next year: BMO
2 days ago
In an interview with BMO Capital Markets, a prominent former FDA official...
TV drug ad spending continues upward climb, logging nearly 30% growth in Q1
2 days ago
Pharma advertisers have kicked off 2025 with a bang, with the top...